p53 codon 72 polymorphism and Hematological Cancer Risk: An Update Meta-Analysis

• Yu Weng ,

  Contributed equally to this work with: Yu Weng, Liqin Lu, Jun Zhang

  Affiliation Department of Clinical Laboratory, Zhejiang Univerisity School of Medicine, Sir Run Run Shaw Hospital, Hangzhou, China

  ⨯
• Liqin Lu ,

  Contributed equally to this work with: Yu Weng, Liqin Lu, Jun Zhang

  Affiliation Department of Oncology, Zhejiang Provincial People’s Hospital, Hangzhou, China

  ⨯
• Guorong Yuan,

  Affiliation Department of Oncology, Zhejiang Provincial People’s Hospital, Hangzhou, China

  ⨯
• Jing Guo,

  Affiliation Department of Public Health, Institute of Environmental Health, Zhejiang Univerisity School of Medicine, Hangzhou, China

  ⨯
• Zhizhong Zhang,

  Affiliation Department of Neurology, School of Medicine, Nanjing University, Jinling Hospital, Nanjing, China

  ⨯
• Xinyou Xie,

  Affiliation Department of Clinical Laboratory, Zhejiang Univerisity School of Medicine, Sir Run Run Shaw Hospital, Hangzhou, China

  ⨯
• Guangdi Chen ,

  * E-mail: chenguangdi@gmail.edu.cn

  Affiliation Department of Public Health, Institute of Environmental Health, Zhejiang Univerisity School of Medicine, Hangzhou, China

  ⨯
• Jun Zhang

  Contributed equally to this work with: Yu Weng, Liqin Lu, Jun Zhang

  Affiliation Department of Clinical Laboratory, Zhejiang Univerisity School of Medicine, Sir Run Run Shaw Hospital, Hangzhou, China

  ⨯